Results 71 to 80 of about 3,279,698 (336)
Landscape of BRAF transcript variants in human cancer
We investigate the annotation of BRAF variants, focusing on protein‐coding BRAF‐220 (formerly BRAF‐reference) and BRAF‐204 (BRAF‐X1). The IsoWorm pipeline allows us to quantify these variants in human cancer, starting from RNA‐sequencing data. BRAF‐204 is more abundant than BRAF‐220 and impacts patient survival.
Maurizio S. Podda+5 more
wiley +1 more source
Background Dissemination and outcome reporting biases are a significant problem in clinical research, with far-reaching implications for both scientific understanding and clinical decision-making.
Lydia Pool+6 more
doaj +1 more source
Meta-analyses in psychology often overestimate evidence for and size of effects
Adjusting for publication bias is essential when drawing meta-analytic inferences. However, most methods that adjust for publication bias do not perform well across a range of research conditions, such as the degree of heterogeneity in effect sizes ...
František Bartoš+5 more
doaj +1 more source
Copas' method is sensitive to different mechanisms of publication bias [PDF]
Copas' method corrects a pooled estimate from an aggregated data meta-analysis for publication bias. Its performance has been studied for one particular mechanism of publication bias. We show through simulations that Copas' method is not robust against other realistic mechanisms.
arxiv
MVPBT: R package for publication bias tests in meta-analysis of diagnostic accuracy studies [PDF]
Meta-analysis for diagnostic test accuracy (DTA) has been a standard research method for synthesizing evidence from diagnostic studies. In DTA meta-analysis, although publication bias is an important source of bias, no certain methods similar to the Egger test in univariate meta-analysis have been developed to detect such bias.
arxiv
Publication bias begins at home [PDF]
A few times a year, I have the opportunity to speak to emergency medicine clinicians about how to get their research published. Somewhere during the session, I’ll usually ask how many people have done research, and presented it at a scientific meeting—and the majority of hands go up.
openaire +4 more sources
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton+17 more
wiley +1 more source
Capture-recapture method for assessing publication bias
<p style="line-height: 200%; margin: 0cm 0cm 0pt;"><span style="font-size: small;"><span style="font-family: Times New Roman;"><strong><span style="color: black;">Background</span></strong><span style="color ...
Jalal Poorolajal+5 more
doaj +2 more sources
Publication bias in clinical research
In a retrospective survey, 487 research projects approved by the Central Oxford Research Ethics Committee between 1984 and 1987, were studied for evidence of publication bias. As of May, 1990, 285 of the studies had been analysed by the investigators, and 52% of these had been published.
Easterbrook, P+3 more
openaire +3 more sources
This review highlights how foundation models enhance predictive healthcare by integrating advanced digital twin modeling with multiomics and biomedical data. This approach supports disease management, risk assessment, and personalized medicine, with the goal of optimizing health outcomes through adaptive, interpretable digital simulations, accessible ...
Sakhaa Alsaedi+2 more
wiley +1 more source